Magaldrate

DRUG2 trials

Sponsors

Valenta Pharm JSC, University of Mons

Conditions

Acid-dependent Diseases of the Gastrointestinal TractHeartburnLaryngopharyngeal Reflux DiseaseSymptomatic Treatment of Gastric and Duodenal Ulcers

Phase 4

Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease

Not yet recruitingNCT07611162

University of MonsLaryngopharyngeal Reflux Disease

Start: 2026-05-01End: 2030-05-01Target: 800Updated: 2026-05-28

Unknown Phase

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

CompletedNCT06552624

Valenta Pharm JSCAcid-dependent Diseases of the Gastrointestinal Tract, Heartburn, Symptomatic Treatment of Gastric and Duodenal Ulcers

Start: 2021-07-07End: 2022-08-31Updated: 2024-08-14